TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 23 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,571 | -29.6% | 24,000,000 | -12.7% | 0.02% | -22.2% |
| Q2 2023 | $22,120 | -25.0% | 27,500,000 | -8.3% | 0.03% | -30.8% |
| Q1 2023 | $29,490 | +2.3% | 30,000,000 | -4.8% | 0.04% | -2.5% |
| Q4 2022 | $28,822 | -99.9% | 31,500,000 | +7.7% | 0.04% | -9.1% |
| Q3 2022 | $29,908,000 | +19.3% | 29,250,000 | +17.0% | 0.04% | +29.4% |
| Q2 2022 | $25,075,000 | -9.4% | 25,000,000 | -3.8% | 0.03% | +6.2% |
| Q1 2022 | $27,677,000 | – | 26,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 45,000,000 | $474,089,000 | 9.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $4,280,000 | 0.96% |
| DeepCurrents Investment Group LLC | 22,150,000 | $23,650,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,000,000 | $19,967,000 | 0.46% |
| Context Capital Management, LLC | 5,750 | $6,138,000 | 0.40% |
| WOLVERINE ASSET MANAGEMENT LLC | 34,000,000 | $36,271,000 | 0.35% |
| Polar Asset Management Partners Inc. | 15,000,000 | $15,993,000 | 0.17% |
| LINDEN ADVISORS LP | 20,000,000 | $21,281,000 | 0.13% |
| Wellesley Asset Management | 1,599 | $1,599,000 | 0.11% |
| Verition Fund Management LLC | 6,213,000 | $6,614,000 | 0.08% |